Billing and Coding: MolDX: Molecular Biomarker Testing for Risk Stratification of Cutaneous Squamous Cell Carcinoma

This billing/coding guidance applies to MolDX molecular biomarker testing for risk stratification of cutaneous squamous cell carcinoma and specifies required claim elements. Claims must include the appropriate CPT and ICD-10-CM codes, exactly 1 unit of service, and the DEX Z-Code placed adjacent to the CPT code in the specified Part A/Part B claim fields (with no extra characters on SV101-7 for Part B).

"Use this billing/coding guidance when submitting claims for MolDX molecular biomarker testing for risk stratification of cutaneous squamous cell carcinoma (cSCC)."

Sign up to see full coverage criteria, indications, and limitations.